Health
New vaccine to ‘provide 2-year protection’ – ecns
An adenovirus vector vaccine against COVID-19 by CanSino Biologics is projected to provide protection for two years if a booster shot is administered, said a scientist…
Special: Battle Against Novel CoronavirusAn adenovirus vector vaccine against COVID-19 by CanSino Biologics is projected to provide protection for two years if a booster shot is administered, said a scientist who played a key role in the vaccine’s development.
The Chinese National Medical Products Administration granted conditional market approval to the vaccine on Thursday.
The vaccine, called Ad5-nCoV, has an efficacy rate of 65.7 percent at preventing symptomatic cases and is 90.9 percent effective…
-
General10 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Business18 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News22 hours agoResilience features in Sunshine Coast Open House
-
Noosa News16 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025